Crispin R. Dass

20.1k total citations · 2 hit papers
223 papers, 11.5k citations indexed

About

Crispin R. Dass is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Crispin R. Dass has authored 223 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 41 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Crispin R. Dass's work include RNA Interference and Gene Delivery (56 papers), Advanced biosensing and bioanalysis techniques (41 papers) and Nanoparticle-Based Drug Delivery (31 papers). Crispin R. Dass is often cited by papers focused on RNA Interference and Gene Delivery (56 papers), Advanced biosensing and bioanalysis techniques (41 papers) and Nanoparticle-Based Drug Delivery (31 papers). Crispin R. Dass collaborates with scholars based in Australia, United States and Thailand. Crispin R. Dass's co-authors include Peter Choong, Pornsak Sriamornsak, Hani Al‐Salami, Chun Yuen Jerry Wong, Dave E. Dunstan, Mei Lin Tan, Jonathan C. M. Clark, Hang T. Ta, Levon M. Khachigian and Eugene T. Ek and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Crispin R. Dass

219 papers receiving 11.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

2012 2.0k citations Pornsak Sriamornsak, Crispin R. Dass et al. Journal of Pharmacy and Pharmacology profile →
Current research on pharmacologic and regenerative therapies for osteoarthritis

2016 379 citations Crispin R. Dass et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Crispin R. Dass Australia	54	5.7k	2.3k	1.8k	1.7k	1.6k	223	11.5k
Nosratollah Zarghami Iran	56	5.6k 1.0×	3.7k 1.6×	3.0k 1.7×	1.1k 0.7×	1.2k 0.8×	375	13.8k
Wei He China	49	4.5k 0.8×	2.3k 1.0×	2.4k 1.4×	1.3k 0.7×	677 0.4×	248	11.3k
Man Li China	56	3.8k 0.7×	1.5k 0.7×	2.2k 1.2×	1.9k 1.1×	1.0k 0.7×	354	9.8k
Mahmoud Reza Jaafari Iran	60	5.0k 0.9×	2.9k 1.3×	2.2k 1.2×	1.2k 0.7×	1.4k 0.9×	387	11.8k
Yoshinobu Takakura Japan	61	10.3k 1.8×	1.9k 0.8×	1.9k 1.1×	1.2k 0.7×	2.4k 1.6×	360	14.6k
Timo L.M. ten Hagen Netherlands	49	3.6k 0.6×	2.7k 1.1×	3.1k 1.7×	1.8k 1.1×	899 0.6×	212	8.8k
Jianqing Gao China	69	6.2k 1.1×	3.8k 1.6×	4.3k 2.4×	1.1k 0.6×	1.1k 0.7×	343	14.6k
Yu Zhang China	57	3.6k 0.6×	3.4k 1.4×	3.2k 1.8×	1.6k 0.9×	767 0.5×	508	12.5k
Milad Ashrafizadeh Iran	72	7.2k 1.3×	1.9k 0.8×	2.2k 1.2×	1.8k 1.0×	3.4k 2.2×	265	14.3k
Tatsuhiro Ishida Japan	58	6.9k 1.2×	5.5k 2.4×	2.7k 1.5×	1.5k 0.9×	781 0.5×	282	12.8k

Countries citing papers authored by Crispin R. Dass

Since Specialization

Citations

This map shows the geographic impact of Crispin R. Dass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crispin R. Dass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crispin R. Dass more than expected).

Fields of papers citing papers by Crispin R. Dass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crispin R. Dass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crispin R. Dass. The network helps show where Crispin R. Dass may publish in the future.

Co-authorship network of co-authors of Crispin R. Dass

This figure shows the co-authorship network connecting the top 25 collaborators of Crispin R. Dass. A scholar is included among the top collaborators of Crispin R. Dass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crispin R. Dass. Crispin R. Dass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Salami, Hani, et al.. (2024). Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways. International Journal of Molecular Sciences. 25(5). 2755–2755. 4 indexed citations

Dass, Crispin R., et al.. (2024). Current treatments for oropharyngeal squamous cell carcinoma and the move towards molecular therapy. Journal of Pharmacy and Pharmacology. 76(12). 1552–1562.

Luna, Giuseppe, et al.. (2023). Metabolomics Profiling Reveals the Role of PEDF in Triple-Negative Breast Cancer Cell MDA-MB-231 under Glycaemic Loading. Pharmaceutics. 15(2). 543–543. 5 indexed citations

Luna, Giuseppe, et al.. (2023). Novel Silicone-Grafted Alginate as a Drug Delivery Scaffold: Pharmaceutical Characterization of Gliclazide-Loaded Silicone-Based Composite Microcapsules. Pharmaceutics. 15(2). 530–530. 4 indexed citations

Ardalani, Hamidreza, et al.. (2022). Metabolomics—A Tool to Find Metabolism of Endocrine Cancer. Metabolites. 12(11). 1154–1154. 12 indexed citations

Suttiruengwong, Supakij, et al.. (2021). Impact of Drug Loading Method on Drug Release from 3D-Printed Tablets Made from Filaments Fabricated by Hot-Melt Extrusion and Impregnation Processes. Pharmaceutics. 13(10). 1607–1607. 30 indexed citations

Elahy, Mina, et al.. (2014). Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy. Journal of Endocrinology. 222(3). R129–R139. 47 indexed citations

Fílíz, Gülaydan & Crispin R. Dass. (2012). Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation.. PubMed. 67(12). 1010–4. 16 indexed citations

Kim, Soo-Hyun & Crispin R. Dass. (2011). Induction of Caspase-2 Activation by a DNA Enzyme Evokes Tumor Cell Apoptosis. DNA and Cell Biology. 31(1). 1–7. 8 indexed citations

10.

Broadhead, Matthew L., Crispin R. Dass, & Peter Choong. (2011). Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model. British Journal of Cancer. 105(10). 1503–1511. 32 indexed citations

11.

Dass, Crispin R. & Peter Choong. (2010). Sequence-Related Off-Target Effect of Dz13 Against Human Tumor Cells and Safety in Adult and Fetal Mice Following Systemic Administration. Oligonucleotides. 20(2). 51–60. 16 indexed citations

12.

Ta, Hang T., Crispin R. Dass, Peter Choong, & Dave E. Dunstan. (2009). Osteosarcoma treatment: state of the art. Cancer and Metastasis Reviews. 28(1-2). 247–263. 245 indexed citations

13.

Dass, Crispin R., Levon M. Khachigian, & Peter Choong. (2008). c-Jun knockdown sensitizes osteosarcoma to doxorubicin. Molecular Cancer Therapeutics. 7(7). 1909–1912. 32 indexed citations

14.

Dass, Crispin R., Anna Friedhuber, Levon M. Khachigian, Dave E. Dunstan, & Peter Choong. (2008). Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. Journal of Microencapsulation. 25(6). 421–425. 28 indexed citations

15.

Dass, Crispin R. & Peter Choong. (2008). Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic.. PubMed. 63(1). 4–6. 1 indexed citations

16.

Bhindi, Ravinay, Roger G. Fahmy, Harry C. Lowe, et al.. (2007). Brothers in Arms. American Journal Of Pathology. 171(4). 1079–1088. 98 indexed citations

17.

Dass, Crispin R., et al.. (2005). Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma. Clinical & Experimental Metastasis. 22(8). 643–652. 43 indexed citations

18.

Dass, Crispin R. & Mark A. Burton. (2002). A Model for Evaluating Selective Delivery of Plasmid DNA to Tumours via the Vasculature. Cancer Biotherapy and Radiopharmaceuticals. 17(5). 501–505. 14 indexed citations

19.

Dass, Crispin R.. (2001). Formulation and quality control of cationic liposomes. 19(1). 18–23. 1 indexed citations

20.

Dass, Crispin R., et al.. (1996). In‐vitro Evaluation of Ion‐exchange Microspheres as Carriers for Plasmid DNA. Pharmacy and Pharmacology Communications. 2(9). 401–405. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact